Search results
Results From The WOW.Com Content Network
National Donor Deferral Registry. The National Donor Deferral Registry, also known as the (NDDR) is a database of individuals who have tested "reactive" for viral agents like human immunodeficiency viruses (HIV), Hepatitis B virus (HBV), and hepatitis C virus (HCV) and are permanently prohibited from donating plasma. [ 1]
Vitalant is the nation’s largest independent, nonprofit blood services provider exclusively focused on providing blood and comprehensive transfusion medicine services. [2] The organization comprises a network of about 120 donation centers across the U.S. and are the sole blood provider to about 900 hospitals across the United States.
Grifols. Grifols, S.A. ( Catalan: [ˈɡɾifuls]) is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma –based products, a field in which it is the European leader and largest worldwide, [ 3][ 4] the company also supplies devices, instruments, and reagents for clinical testing laboratories .
The NCAA recently contracted with a company to create a voluntary registry for agents, service providers and deals over $600, which may yield better information about the estimated $1.2 billion ...
Donors through the Seattle Sperm Bank earn $100 per approved donation, with the potential to earn $1,500 a month, plus referral bonuses. Donors through the Sperm Bank of California earn $150 per ...
Saiff’s scenario — including his confusion — is prevalent. And with 4.1 million Americans turning 65 this year — a record number — the decision is front and center in many households ...
The National Marrow Donor Program (NMDP) is a nonprofit organization founded in 1987 and based in Minneapolis, Minnesota, that operates the Be The Match Registry of volunteer hematopoietic cell donors and umbilical cord blood units in the United States . The Be The Match Registry is the world's largest hematopoietic cell registry, listing more ...
August 2, 2024 at 10:20 AM. By Mariam Sunny. (Reuters) -The U.S. Food and Drug Administration said on Friday it has approved Adaptimmune's first-of-its-kind treatment for a rare type of cancer in ...